60

Zhejiang Shengda Bio-Pharm Co LtdSHG 603079 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

0.263

Micro

Exchange

XSHG - Shanghai Stock Exchange

603079.SS Stock Analysis

60

Uncovered

Zhejiang Shengda Bio-Pharm Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

2/100

Low score

Market cap $B

0.263

Dividend yield

0.58 %

Shares outstanding

171.19 B

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives. The company is headquartered in Taizhou, Zhejiang and currently employs 1,114 full-time employees. The company went IPO on 2017-08-23. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The firm distributes its products in domestic market and to overseas markets.

View Section: Eyestock Rating